Shilpa Medicare Telangana facility gets EIR from USFDA Medical Dialogues Bureau26 Oct 2019 6:16 AM GMT"The USFDA has concluded that the inspection classification of Jadcherla facility was "voluntary action indicated". This facility is in an acceptable...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sep 2019 9:45 AM GMT"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
Shilpa Medicare gets 2 USFDA observations for Telangana facility Medical Dialogues Bureau9 Sep 2019 6:20 AM GMTThe US Food and Drug Administration (USFDA) inspected the company's finished dosage formulation facility located at Pharmaceutical Formulations SEZ,...
Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 4:30 AM GMTThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
Sun Pharma and SPARC's XELPROS gets USFDA approval Medical Dialogues Bureau15 Sep 2018 11:02 AM GMTUS Food and Drug Administration (USFDA) has approved the SPARC new drug application of XELPROS, used to reduce glaucoma open-angle glaucoma or ocular...
